I heard a muffled sound, was it them? Guess not, nothing fruitful to add by the head or other end. It's too bad, they lost all that rent money and beer money and McDonalds Happy Meal money.
Yes, and they should instantly replace any kayexylate usage, Sanofi knew what they were doing divesting it to Covis. Anyway, that bodes well for successful launch.
Yes most new short (millions) came in Oct. 16 and 19. They are underwater bigtime. The info is readily available.
The Zohydro case is relevant. FDA can not discriminate, without grounds, or has to pull all similar current drugs from market.
Yes, takes a while to make offers, those two were good buyouts. CHTP DRTX
$100 Million enterprise valuation when you take into account $100 million cash on hand (Market cap - cash = enterprise valuation), is too low for a company with 2 phase III projects and already EU approval. Look for blast higher any day now.
Lurcher, RLYP, pump it, c'mon, Adam F. saved that one for you and golong heights. CEMP is fine I have a lot, got me some RLYP, need to get that one up out. It should move up to Jan. launch.